Bococizumab is a cutting-edge anti-PCSK9 antibody specifically developed to combat hypercholesterolemia. Such therapeutic agent interacts with the PCSK9 protein, a critical regulator of cholesterol amounts. By blocking https://gorillasocialwork.com/story26525028/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia